Fifteen Years' Experience of Home Care During the Pancytopenic Phase After Allogeneic Hematopoietic Stem Cell Transplantation

Median age; years (range) 59 (26-72) Male (%) 13 (65%) Diagnosis, no. (%) Acute Myeloid Leukemia 4 (20%) Non-Hodgkin Lymphoma 11 (55%) Chronic Leukemia (CLL or CML) 4 (20%) Hemophagocytic syndrome 1 (5%) Disease risk, no. (%) High risk 5 Intermediate risk 10 Low risk 4 Prior autografting, no. (%) Yes 1 (5%) No 19 (95%) Donors, no. (%) Related 5 (25%) Unrelated 15 (75%) Sex mismatch, no (%) M to M 9 (45%) M to F 3 (15%) F to M 4 (20%) F to F 4 (20%) Degree of HLA match, no. (%) 10/10 19 (95%) 9/10 1 (5%) Median KPS; (range) 80 (70-100) Median HCT-CI; (range) 1 (0-5) Median CD34 cell dosey (10 cells/kg recipient body weight), (range) 5.7 (1.5-11.3) Abstracts / Biol Blood Marrow Transplant 19 (2013) S313eS341 S339